Companies House does not verify the accuracy of the information filed(link opens a new window)
Advanced company searchLink opens in new window

ASTELLAS ENGINEERED SMALL MOLECULES U.K. LIMITED

Company number 08328823

Follow this company File for this company
Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
13 Apr 2024 RESOLUTIONS Resolutions
  • RES11 ‐ Resolution of removal of pre-emption rights
  • RES10 ‐ Resolution of allotment of securities
03 Apr 2024 CERTNM Company name changed nanna therapeutics LIMITED\certificate issued on 03/04/24
  • NM01 ‐ Change of name by resolution
  • RES15 ‐ Change company name resolution on 2024-04-02
17 Feb 2024 RP04SH01 Second filing of a statement of capital following an allotment of shares on 28 September 2021
  • GBP 4,622.933
28 Nov 2023 SH01 Statement of capital following an allotment of shares on 23 November 2023
  • GBP 4,782.933
07 Nov 2023 CS01 Confirmation statement made on 5 November 2023 with updates
18 Oct 2023 AA Total exemption full accounts made up to 31 March 2023
10 Aug 2023 SH01 Statement of capital following an allotment of shares on 17 July 2023
  • GBP 4,762.933
07 Aug 2023 SH01 Statement of capital following an allotment of shares on 17 July 2023
  • GBP 4,732.933
31 Jul 2023 SH01 Statement of capital following an allotment of shares on 25 April 2022
  • GBP 4,732.933
19 Apr 2023 SH01 Statement of capital following an allotment of shares on 14 April 2023
  • GBP 4,732.933
23 Nov 2022 AA Total exemption full accounts made up to 31 March 2022
07 Nov 2022 CS01 Confirmation statement made on 5 November 2022 with updates
01 Sep 2022 TM01 Termination of appointment of Yoshitsugu Shitaka as a director on 24 August 2022
01 Sep 2022 AP01 Appointment of Dr David Barrett as a director on 24 August 2022
24 May 2022 RESOLUTIONS Resolutions
  • RES11 ‐ Resolution of removal of pre-emption rights
  • RES10 ‐ Resolution of allotment of securities
19 May 2022 SH01 Statement of capital following an allotment of shares on 25 April 2022
  • GBP 4,672.933
06 Apr 2022 AA Total exemption full accounts made up to 31 March 2021
05 Nov 2021 CS01 Confirmation statement made on 5 November 2021 with updates
26 Oct 2021 SH01 Statement of capital following an allotment of shares on 28 September 2021
  • GBP 4,622.933
  • ANNOTATION Clarification a second filed SH01 was registered on 17/02/2024.
26 Oct 2021 TM01 Termination of appointment of David Hugh Williams as a director on 15 October 2021
21 Sep 2021 AP01 Appointment of Mr. Yoshitsugu Shitaka as a director on 13 September 2021
14 Sep 2021 TM01 Termination of appointment of Akihiko Iwai as a director on 31 March 2021
25 Mar 2021 AA Unaudited abridged accounts made up to 31 March 2020
18 Jan 2021 CS01 Confirmation statement made on 12 December 2020 with updates
13 Jan 2021 SH01 Statement of capital following an allotment of shares on 16 December 2020
  • GBP 4,532.933